40 MARCUS DRIVE, MELVILLE, NY
Market cap: $2.2M (2/11/2026)
Price: $0.25
Investor Presentation
Announces $1.085 Million Registered Direct Offering Priced Above Market
Shareholder votes
Patient Numbers Up: From 15 to 36 subjects since last update, nearing Phase 2 goal of 99.
Financial Results, Reg. FD
Changing the Company's Accountant
Q3
Q2
Q1
FY 2024
Amended Annual Report
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership